PARAMETRIC PORTFOLIO ASSOCIATES LLC - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 41 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q1 2022$1,141,000
-35.3%
114,766
-23.4%
0.00%0.0%
Q4 2021$1,763,000
+120.7%
149,755
+113.5%
0.00%
Q3 2021$799,000
-12.6%
70,146
+6.9%
0.00%
-100.0%
Q2 2021$914,000
-31.5%
65,588
-9.1%
0.00%0.0%
Q1 2021$1,335,000
+12.5%
72,143
+7.4%
0.00%0.0%
Q4 2020$1,187,000
+113.9%
67,169
+85.3%
0.00%
Q3 2020$555,000
-34.1%
36,256
+9.8%
0.00%
-100.0%
Q2 2020$842,000
+34.3%
33,034
-18.5%
0.00%0.0%
Q1 2020$627,000
-3.7%
40,532
-31.1%
0.00%
Q4 2019$651,000
+48.3%
58,857
+14.1%
0.00%
Q3 2019$439,000
+2.6%
51,572
+63.2%
0.00%
Q2 2019$428,000
-11.6%
31,595
+17.9%
0.00%
Q1 2019$484,000
-23.7%
26,808
+18.8%
0.00%
-100.0%
Q4 2018$634,000
+3.9%
22,565
-5.7%
0.00%0.0%
Q3 2018$610,000
+110.3%
23,922
+43.2%
0.00%
Q2 2018$290,00016,7040.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q2 2018
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 2,474,561$42,983,1255.17%
Rubric Capital Management LP 3,077,449$53,455,2892.00%
Parkman Healthcare Partners LLC 509,810$8,855,4001.62%
TANG CAPITAL MANAGEMENT LLC 600,000$10,422,0001.47%
AlphaCentric Advisors LLC 110,000$1,910,7001.08%
Lion Point Capital, LP 130,691$2,270,1031.01%
RICE HALL JAMES & ASSOCIATES, LLC 650,366$11,296,8570.72%
ESSEX INVESTMENT MANAGEMENT CO LLC 185,853$3,228,2670.53%
ADVISORY RESEARCH INC 204,098$3,545,1820.49%
Jackson Creek Investment Advisors LLC 65,607$1,1400.48%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders